NCT04107168 2023-02-16
Microbiome Immunotherapy Toxicity and Response Evaluation
Cambridge University Hospitals NHS Foundation Trust
Unknown
Clinical Trials
5 trialsNCT04988607 2021-08-03
Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC
Guangdong Association of Clinical Trials
Phase 2 Unknown
NCT04788381 2021-03-09
The Effects of Preoperative Bevacizumab on Perioperative Complications
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT02139579 2014-05-15
Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT01623102 2013-02-12
Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown